2-(Benzo[4,5]thiazolo[2,3-c][1,2,4]triazol-3-ylthio)-1-(4-methylpiperidin-1-yl)ethan-1-one

Catalog No. :
ACUDUT502
CAS No. :
374693-57-9
Molecular Formula :
C16H18N4OS2
Molecular Weight :
346.48

IUPAC Name:2-(benzo[4,5]thiazolo[2,3-c][1,2,4]triazol-3-ylthio)-1-(4-methylpiperidin-1-yl)ethan-1-one

2-(Benzo[4,5]thiazolo[2,3-c][1,2,4]triazol-3-ylthio)-1-(4-methylpiperidin-1-yl)ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Benzo[4,5]thiazolo[2,3-c][1,2,4]triazol-3-ylthio)-1-(4-methylpiperidin-1-yl)ethan-1-one
IUPAC Name2-(benzo[4,5]thiazolo[2,3-c][1,2,4]triazol-3-ylthio)-1-(4-methylpiperidin-1-yl)ethan-1-one
Molecular FormulaC16H18N4OS2
Molecular Weight346.48
SMILESO=C(N1CCC(C)CC1)CSC2=NN=C3N2C4=CC=CC=C4S3
InChI KeyRUYSMPJYEJBJPC-UHFFFAOYSA-N
Synonym2-(benzo[4,5]thiazolo[2,3-c][1,2,4]triazol-3-ylthio)-1-(4-methylpiperidin-1-yl)ethan-1-one;2-(4-methylpiperidin-1-yl)-2-oxoethyl [1,2,4]triazolo[3,4-b][1,3]benzothiazol-3-yl sulfide;Ethanone, 1-(4-methyl-1-piperidinyl)-2-(1,2,4-triazolo[3,4-b]benzothiazol-3-ylthio)-;3((2(4-ME-1-PIPERIDINYL)2-OXOETHYL)THIO)(1,2,4)TRIAZOLO(3,4-B)(1,3)BENZOTHIAZOLE
CAS No.374693-57-9

Synthetic Route by SureRoute

1. ACUDUT502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUDUT502 route product structure diagram
    ACUDUT502374693-57-9
Inquiry

2. ACUDUT502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJFGT165 route compound structure diagram
    ACJFGT1654593-20-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUDUT502 route product structure diagram
    ACUDUT502374693-57-9
Inquiry

Comments (0)